Lakewood-Amedex Biotherapeutics
LABT
#11175
Rank
โ‚น0.19 B
Marketcap
โ‚น83.54
Share price
1.42%
Change (1 day)
N/A
Change (1 year)
Categories

Lakewood-Amedex Biotherapeutics (LABT) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : โ‚น60.6 Million

According to Lakewood-Amedex Biotherapeutics's latest financial reports the company's total liabilities are โ‚น60.6 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Lakewood-Amedex Biotherapeutics - Total liabilities on balance sheet (from 2024 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31โ‚น0.21 B287.26%
2024-12-31โ‚น56.7 M-70.84%
2023-12-31โ‚น0.19 B